FoCUS Monthly Recap: February 2020

Eric NormanFoCUS, News

NOW ONLINE
Paying for Cures Toolkit

Research, strategies, and do-it-yourself analysis tools will help you understand the potential impact of new therapies and plan for practice and policy innovation. Visit the Toolkit

SOLD OUT
Paying for Cures Workshop
March 10 at MIT

Survey the financial challenges of sustaining new cell and gene therapies, assess adoption barriers, and anticipate coming changes in practice and policy. Special focus on challenges and solutions for private and public healthcare payers.
See the agenda

FoCUS IN THE MEDIA
Health Affairs • January 30
Managing Uncertainty In Drug Value: Outcomes-Based Contracting Supports Value-Based Pricing

Mellon Double Take Podcast
Gene Therapy: Cures, Risks and Opportunities
Dan Mytelka speaks about the FoCUS project’s discoveries and strategies

FoCUS IN THE COMMUNITY
Mark Trusheim participated in the MassBio Policy Breakfast in Boston on January 29, spoke at the BCBSA/Aspen Institute Advanced Therapies event in Washington DC on February 7, participated in the Milken Institute FasterCures Data Collection Challenges Workshop in Washington, DC on February 13, and spoke at the American Society for Transplantation and Cellular Therapy / CIBMTR TCT Meeting in Orlando on February 21.

February 7, Danielle Rollmann attended the Medicaid Innovations Forum in Orlando and represented FoCUS in a panel titled “Guiding the Future of Pharmacy Benefits: Adapting to Gene Therapy and Ultra High-Cost Drugs to Make Leading-edge Care Affordable.”

…and coming up: 
Jane Barlow will speak at MedImpact 2020 in Carlsbad, March 23–25

Mark Trusheim will speak at Hanson-Wade 4th Annual Gene Therapy for Rare Disorders, March 30 in Boston

DESIGN LAB
The next FoCUS Design Lab will be held April 28–30 in Boston. Invitation only